探讨硝普钠、多巴胺联合持续静脉泵入治疗老年顽固性心力衰竭的效果

Study on Sodium Nitroprusside and Dopamine Combined With Continuous Intravenous Infusion in Elderly Patients With Refractory Heart Failure

目的研究分析老年顽固性心力衰竭患者接受硝普钠、多巴胺联合持续静脉泵入治疗的效果。方法对70例顽固性老年心力衰竭患者进行研究,将其分成两组,对照组和研究组均为35例患者,全部患者均接受了常规处理,研究组患者增加了硝普钠、多巴胺联合静脉泵入治疗。对两组的临床治疗情况进行观察分析,比较患者的心功能改善情况和不良反应情况。结果研究组的临床治疗有效率是97.14%,对照组是85.71%,两组的临床治疗有效率对比差异有统计学意义(P<0.05)。两组的LVEF、心率治疗前差异无统计学意义(P>0.05)。研究组不良反应率是8.57%,对照组是8.57%,结果差异无统计学意义(P>0.05)。结论硝普钠、多巴胺联合治疗老年顽固性心力衰竭具有比较好的效果,患者心功能改善明显,不良反应较少。

Objective To study the elderly patients with refractory heart failure to accept the inquiry of sodium nitroprusside and dopamine combined with continuous intravenous infusion therapy. Methods In our hospital, 70 cases of refractory heart failure patients were studied and divided into two groups, the control group and the study group were respectively 35 patients. All patients received routine treatment, patients in the study group increased sodium nitroprusside and dopamine combined with intravenous infusion therapy. The clinical treatment of the two groups were observed and analyzed, and the improvement of cardiac function and adverse reactions were compared. Results The clinical effective rate was 97.14% in the study group and the control group was 85.71%. There was statistical difference between the two groups （P〈0.05）. There was no statistical difference between the two groups of LVEF and heart rate before treatment （P〉0.05）. The adverse reaction rate was 8.57% in the study group and the control group was 8.57%, and there was no significant difference （P〉0.05）. Conclusion Sodium nitroprusside and dopamine in the treatment of refractory heart failure in the elderly has a good effect, the cardiac function of the patients improved significantly, has less adverse reaction.